Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension Study of Pimavanserin in Psychosis in Parkinson's Disease
2007-003035-22Phase 3Completed
- Sponsor
- Acadia Pharmaceuticals
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pimavanserin in Parkinson's disease (PD), sponsored by Acadia Pharmaceuticals. Started Dec 2007; status: completed.
02
Drugs
pimavanserin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2007-003035-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003035-22.